AV-Comparatives Announces Outstanding Results of Cybersecurity Solutions in 2024 Endpoint Prevention and Response (EPR) Test
Download the full report here. INNSBRUCK, Austria, Dec. 11, 2024 /PRNewswire/ --…
Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivatat ASH 2024 and Provides Regulatory Update on Mitapivat
– ENERGIZE-T Study Achieved Primary and All Key Secondary Endpoints in Adult…
Five-year results confirm Roches Polivy combination therapy as new standard of care for previously untreated aggressive lymphoma
Exploratory long-term follow-up analysis of the phase III POLARIX study indicated a…
Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
Data from the ongoing Phase 1/2 ATALANTA-1 study in a heavily pretreated…
Secureworks Announces Third Quarter Fiscal 2025 Results
ATLANTA, Dec. 4, 2024 /PRNewswire/ -- Secureworks® (NASDAQ: SCWX), a global leader…
Descartes Announces Fiscal 2025 Third Quarter Financial Results
Record Revenues as Global Logistics Network ExpandsWATERLOO, Ontario and ATLANTA, Dec. 03,…
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update
— Enhanced liquidity through issuance of Second Lien Notes — Obtained amendment…
Kia Announces November 2024 Global Sales Results
November 2024 global sales of 262,426 units, up 0.8% Y/yOutside of Korea,…
Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update
All dollar amounts reflected in Canadian dollars unless otherwise stated November 29,…
Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update
All dollar amounts reflected in Canadian dollars unless otherwise stated November 29,…